This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoya Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Mizue Yamagata: Innovator in Biopharmaceuticals
Introduction
Mizue Yamagata is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative work on peptides. Her research focuses on developing substances that can specifically bind to epidermal growth factor receptors (EGFR), which play a crucial role in various cellular processes.
Latest Patents
Mizue Yamagata holds a patent for an EGFR-binding peptide. This invention provides a substance capable of binding to EGFR with high specificity and affinity. The patent describes a peptide composed of 12 to 50 amino acids, which includes at least one of the specified amino acid sequences. This advancement has potential applications in therapeutic agents targeting diseases associated with EGFR.
Career Highlights
Yamagata is associated with Hoya Corporation, where she continues to push the boundaries of innovation in her field. Her work has not only contributed to the scientific community but also holds promise for future medical applications.
Collaborations
Mizue Yamagata collaborates with notable colleagues, including Yusuke Iimori and Toshitaka Shiono. Their combined expertise enhances the research and development efforts within their projects.
Conclusion
Mizue Yamagata is a trailblazer in the realm of biopharmaceuticals, with her patent on EGFR-binding peptides showcasing her innovative spirit. Her contributions are paving the way for advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile